Lupin receives tentative USFDA’s approval for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
This product would be manufactured at Lupin's Nagpur facility in India
This product would be manufactured at Lupin's Nagpur facility in India
The ANDA was filed as 'First to File' submission on NCE-1 date.
This product will be manufactured at Lupin’s Nagpur facility in India
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
Subscribe To Our Newsletter & Stay Updated